Biotech investors are constantly faced with a dilemma. Buy the safer names, which come with lower risk but whose sheer size prevents them from producing multi-bagger returns? Or look to the small-caps, which certainly hold the ability to multiply an investment many times over, but often come with enormous risks?
To find a company that offers the best of both worlds it sometimes makes sense to look at the mid-cap companies, as they tend to occupy that goldilocks sweet spot -- not too big and not too risky. We asked our team of Motley Fool contributors to share biotech investment ideas that have market caps between $2 and $10 billion that have them excited. Read below to see if you agree with their suggestions.
Hey, check out all the research scientist jobs. Post your resume today!
